Keywords: pharmaswiss, licenses, rights, biosante, elestrin, israel, usa

PharmaSwiss licenses rights to BioSante's Elestrin in Israel

Article | 22 December 2008

Print This

The USA's BioSante Pharmaceuticals has licensed marketing rights for Elestrin (estradiol gel) in Israel to Swiss firm PharmaSwiss SA. The ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in